Related Experiment Video
Updated: Jan 6, 2026

Isolation of CD133+ Liver Stem Cells for Clonal Expansion
Published on: October 10, 2011
Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives
Seong Hee Kang1,2,3, Moon Young Kim1,2, Young Woo Eom1,2
1Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.
Abstract:
Mesenchymal stem cell transplantation is an emerging therapy for treating chronic liver diseases. The potential of this treatment has been evaluated in preclinical and clinical studies. Although the mechanisms of mesenchymal stem cell transplantation are still not completely understood, accumulating evidence has revealed that their immunomodulation, differentiation, and antifibrotic properties play a crucial role in liver regeneration. The safety and therapeutic effects of mesenchymal stem cells in patients with chronic liver disease have been observed in many clinical studies. However, only modest improvements have been seen, partly because of the limited feasibility of transplanted cells at present. Here, we discuss several strategies targeted at improving viable cell engraftment and the potential challenges in the use of extracellular vesicle-based therapies for liver disease in the future.
Insights
Mesenchymal stem cell transplantation shows promise for chronic liver disease, but limited cell engraftment hinders efficacy. Future strategies focus on improving cell viability and exploring extracellular vesicle therapies for better outcomes.
Area of Science:
- Regenerative Medicine
- Hepatology
- Immunology
Background:
- Mesenchymal stem cell (MSC) transplantation is an emerging therapy for chronic liver diseases.
- MSC mechanisms involve immunomodulation, differentiation, and antifibrotic properties crucial for liver regeneration.
- Clinical studies show MSC therapy is safe but offers modest improvements due to limited cell engraftment.
Purpose of the Study:
- To review strategies for enhancing mesenchymal stem cell engraftment in liver disease.
- To discuss the potential and challenges of extracellular vesicle-based therapies for liver disease.
Main Methods:
- Review of preclinical and clinical studies on MSC transplantation for chronic liver diseases.
- Analysis of current literature on MSC mechanisms (immunomodulation, differentiation, antifibrotic effects).
- Exploration of future therapeutic strategies, including cell engraftment enhancement and vesicle-based approaches.
Main Results:
- MSC transplantation demonstrates safety and therapeutic potential in chronic liver disease patients.
- Limited engraftment of transplanted cells is a significant barrier to achieving substantial therapeutic effects.
- Extracellular vesicles (EVs) represent a promising alternative or adjunct therapy.
Conclusions:
- Improving viable cell engraftment is critical for advancing MSC therapy in liver disease.
- EV-based therapies offer a potential future direction for treating liver diseases, overcoming some limitations of cell transplantation.
- Further research is needed to optimize MSC engraftment and fully realize the potential of EV therapies.
Related Concept Videos
Mesenchymal Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Stem Cell Culture
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
iPS Cell Differentiation

